2024-10-01 - Analysis Report
## Cigna Group (CI) Stock Analysis:

**Company Overview:** Cigna Group is a global health service company offering health insurance, pharmacy benefits, and other related services.

**Performance Analysis:**

1. **Relative Performance:**
    * **Cumulative Return:** CI has returned 156.74% compared to the S&P 500 (VOO) with 133.28% return.
    * **Performance Gap:** CI outperforms VOO by 23.46%, which falls in the 49.1% percentile relative to its historical performance range.

2. **Recent Price Movement:**
    * **Closing Price:** $349.92
    * **Moving Averages:**
        * 5-day: $350.33
        * 20-day: $357.26
        * 60-day: $345.14

3. **Technical Indicators:**
    * **RSI:** 40.12 (Neutral)
    * **PPO:** -0.6 (Slight Bearish)
    * **Delta_Previous_Relative_Divergence:** -9.65 (Short-term Downward Trend)
    * **Expected Return:** 8.93% (Estimated 5-year expected return on current investment)

4. **Recent Earnings and Outlook:**
    * **Earnings Trend:** Cigna has shown mixed earnings performance in recent quarters. 
        * The most recent quarter (2024-08-01) saw a strong EPS of 5.51, exceeding analysts' expectations.
        * However, the previous quarter (2024-05-02) saw a significant drop in EPS to -0.97, attributed to higher healthcare costs and regulatory changes.
    * **Outlook:** The company's long-term outlook remains positive, driven by the aging population and increasing demand for health services. However, the recent earnings volatility and regulatory pressures pose short-term challenges.

5. **News and Recent Issues:**

    * **Recent Market Outlook:**  FINBOLD projects a moderate upward trend for Cigna, citing strong growth in the health insurance market and Cigna's robust financial position.
    * **Analyst Opinions:**  Analysts are generally bullish on Cigna's future performance, with most maintaining "buy" or "hold" ratings. However, concerns remain regarding competition and potential healthcare reform.
    * **Performance Highlights:**  Cigna has been successful in expanding its market share through strategic acquisitions and innovation in its product offerings. 

**Summary:**

* **Strong Relative Performance:** Cigna outperforms the S&P 500 in terms of cumulative returns, despite recent market volatility. 
* **Mixed Technical Indicators:** The RSI and PPO suggest neutral to slightly bearish sentiment. The recent downward trend in relative divergence indicates short-term weakness.
* **Solid Earnings Growth:** Despite recent volatility, Cigna has shown strong EPS growth and exceeding analysts' expectations in the most recent quarter.
* **Positive Long-Term Outlook:**  The company is well-positioned to benefit from the growing demand for healthcare services. 
* **Potential Challenges:**  Short-term concerns exist due to competitive pressures and regulatory uncertainty. 

**Overall, Cigna Group presents a solid investment opportunity with strong long-term growth potential. However, investors should monitor short-term market volatility and regulatory changes closely.** 
